• The Korean Journal of Ecology
• /
• 제27권5호
• /
• pp.283-289
• /
• 2004

2002년 1월부터 12월까지 매월 전북 군산시 인근에 위치한 금강호를 대상으로 항생제 내성균의 월별분포변화와 조사기간 중 분리된 균주를 동정하였다. 종속영양세균의 연중 분포는 4.1±1.0 × 10²- 6.7±1.1×10³ cfu mL/sup -1/의 범주에서 변화하였다. 항생제 내성균의 년중 분포는 ampicillin 내성균의 경우, 1.5±0.7×10-4.3±0.3×10³ cfu mL/sup -l/, chloramphenicol 내성균의 경우, 0-6.4 ±0.4 ×10² cfu mL/sup -1/, gentamicin내성균의 경우, 0-2.8±0.3×10³ cfu mL/sup -1/, kanamycin내성균의 경우, 0-4.5±1.0×10³ cfu mL/sup -1/, 그리고 streptomycin 내성균은 1.0±0.4×10-2.3±0.5×10³ cfu mL/sup -1/의 범주에서 변화하였다. 조사된 항생제 내성균들 중 ampicllin 내성균이 모든 정점에서 가장 높은 균체수를 나타냈다 조사기간 중 60균주의 항생제 내성균이 분리되었으며, 그 중 그람양성 세균은 6균주, 그람음성세균은 54균주를 차지하였다. 항생제 내성균으로 분리된 균주는 Pseudomonas 속, Aeromonas 속, 그리고 Bacillus 속과 Stenotrophomonas 속 등이 우점으로 나타났으며, 이외에도 Enterobacter 속, Sphingobium 속, Variovorax 속, 그리고 Serratia 속, Acinetobacter 속, Mycoplana 속, Psychrobacter 속과 , Xanthomonas 속 등이 포함되었다. 동정된 균들은 ampicillin, kanamycin, chloramphenicol, streptomycin, gentamicin 순으로 높은 내성을 나타났다.

• 생명과학회지
• /
• 제28권12호
• /
• pp.1529-1535
• /
• 2018

우리 인간이 병원성 미생물에 감염되었을 경우에 주로 사용되는 항생제들은 현재 수백 가지가 넘지만 각각의 항생제에 대한 내성세균이 발견되는 빈도수가 가파르게 증가하고 있다. 또한 항생제에 대한 내성이 병원성 세균들 사이에서 빠르게 확산되고 있으나 새로운 항생제가 발견되는 속도는 눈에 띄게 감소하고 있다. 따라서 현 시점에서 우리 주변 환경에서 항생제 내성 세균이 얼마나 많이 존재하는 지에 대한 체계적인 연구가 필요하다고 할 수 있다. 본 연구에서는 현재 의료용으로 널리 사용되고 있는 항생제 중에서 ampicillin에 대한 내성 세균에 대한 조사를 진행하였다. 창원시를 가로지르는 창원천 및 창원대학교 기숙사 앞의 연못에서 미생물 시료를 채취하였다. 각 지점에서 채취된 시료를 분석한 결과 많은 내성 세균들이 나타났는데, 이러한 세균들을 집락의 형태에 따라 몇 그룹으로 나누고 각 그룹을 대표하는 22종 세균들의 genomic DNA를 추출하고, 이것을 template로 사용하는 16S rRNA 유전자 증폭반응을 수행 하였다. 얻어진 산물의 염기서열을 밝히고 genbank의 자료들과 비교해서 분리된 내성세균들을 동정하였다. 그 결과 10개 과, 12개 속, 17종의 세균들이 동정되었으며, 분리된 세균들의 ampicillin에 대한 내성을 조사해 본 결과, 17종 모두가 $50{\mu}g/ml$의 ampicillin 농도에서 증식을 하였고, 이 중에서도 7종의 세균들은 1.5 mg/ml의 농도에서도 증식 가능하다는 것을 알 수 있었다.

• 생명과학회지
• /
• 제22권9호
• /
• pp.1268-1276
• /
• 2012

사람의 감염증 치료에 사용되는 carbapenem계 약제에 대한 내성균의 출현 및 확산은 감염증 치료를 제한할 뿐만 아니라 집단 발병의 원인이 될 수 있다. 이에 본 연구에서는 ${\beta}$-lactam 약제에 내성을 갖는 Pseudomonas aeruginosa (P. aeruginosa)를 대상으로 metallo-beta-lactamase (MBL)의 유전형을 규명함으로써 내성세균의 감염증 치료지침 및 확산방지책 마련에 기초 자료를 제공하고자 하였다. 본 연구의 대상이 된 254개의 임상 검체 중에서 42주의 P. aeruginosa 를 분리하여 imipenem 혹은 meropenem에 내성을 나타내는 Hodge 변법과 EDST에서 각각 28주와 23주가 양성반응을 보였다. DNA의 염기서열 분석결과 $bla_{IMP-6}$ 유전자 보유균이 8주, $bla_{VIM-2}$ 유전자 보유균이 17주로 59.5%(25/42)가 MBL을 생성하는 것으로 나타났다. $bla_{IMP-6}$의 유전자 환경은 $bla_{IMP-6}$-qac-aacA4-$bla_{OXA-1}$-aadA1 유전자 배열을 지니고 있었다. 또한 ERIC PCR 결과 IMP-6과 VIM-2를 생성하는 일부 균주에서 역학적 연관성이 있음이 확인되었다. 본 연구에서 분리한 carbapenem계 항균제 내성 P. aeruginosa가 보유한 $bla_{IMP-6}$ 유전자는 대구지역에서 발병이 보고된 유전자의 gene cassette와 일치하는 것으로 확인되었다. 따라서 이들 세균이 지역사회에 정착하고 있고 이들을 보유한 세균에 의한 감염증 치료시 치료약제에 대한 선택압을 증가시킬 것으로 우려된다. 그러므로 항균제 내성 검사를 통하여 적절한 항균제를 선택하고, 항균제 내성균들의 출현과 확산을 막는 연구가 계속되어야 할 것으로 생각된다.

• 대한의생명과학회지
• /
• 제8권2호
• /
• pp.95-99
• /
• 2002

Endocrine disruptors are chemicals which can be found in our normal daily life. They can be easily ingested through plastic food containers, pesticides, etc. They include DDT, bisphenol A, benzophenone and phenylphenol, etc. Endocrine disruptor can be very harmful and toxic because it disrupts the normal function of the endogenous endocrine system. It has been reported that endocrine disruptor can cause the fatal strike in reproductive system central nervous system and the other part of the body. We have examined if the growth of lactic acid bacteria could be resistant to the endocrine disruptor. We have used Lactobacillus delbruekii as an experimental strain and benzophenone and phenylphenol for the comparison purpose. Experiments included the evaluation of turbidity, absorbance and actual cell counts. Although Lactobacillus delbruekii showed the higher resistance to benzophenone than phenylphenol it was still resistant to both benzophenone and phenylphenol. Because the experimental concentrations of benzophenone and phenylphenol were so high to compare with the actual concentration we meet in daily life, Lactobacillus delbruekii was considered to be sufficient to survive in the environmental concentration of these endocrine disruptors. This study should contribute to the development of fermented beverage with beneficial effect by lactic acid bacteria.

• 한국축산식품학회지
• /
• 제33권3호
• /
• pp.335-340
• /
• 2013

This study screened for radio-resistant strains lactic acid bacteria (LAB) by evaluating their capability to survive exposure to ionizing radiation. Ten strains of LAB - Lactobacillus bulgaricus, Lactobacillus paracasei, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus delbruekii, Lactococcus lactis, Streptococcus thermophilus, Bifidobacterium breve, and Pediocuccos pentosaceus - were selected and subcultuted twice. The LAB was then further cultured for 3 d at $37^{\circ}C$ to reach 7-10 Log colony-forming units (CFU)/mL prior to irradiation and immediately exposed to gamma rays or electron beams with absorbed doses of 0, 1, 2, 3, 4, 5, 6, 8, and 10 kGy. Gamma irradiation gradually decreased the number of the tested viable LAB, and the effect was irradiation dose dependent. A similar effect was found in electron beam-irradiated LAB. Radiation sensitivity of LAB was calculated as $D_{10}$ values, which ranged from 0.26 kGy to 0.9 kGy and 0.5 kGy to 1.44 kGy with exposure to gamma and electron beam irradiation, respectively, in all tested LAB. L. acidophilus was the most resistant to gamma and electron beam irradiation, with $D_{10}$ values of 0.9 kGy and 1.44 kGy, respectively. These results suggest that L. acidophilus might be suitable for the preparation of probiotics as direct-fed microbes for astronauts in extreme space environments.

• 한국임상수의학회지
• /
• 제25권5호
• /
• pp.346-354
• /
• 2008

The combined effects of EDTA-Tris and eighteen antimicrobial agents have been evaluated in eight clinically isolated methicillin-resistant bacteria (Staphylococcus aureus, Escherichia coli, Streptococcus uberis and Streptococcus agalactiae) from bovine mastitis. The antimicrobial activity was evaluated by measuring the minimal bactericidal concentration (MBC) for the antibiotics alone or in combination with EDTA-Tris in Mueller-Hilton broth and milk. Combined use of EDTA-Tris and antibiotics potentiated or antagonized activity of antibiotics against mastitic pathogens. Milk increased the antibiotic potency of erythromycin and spiramycin on S. aureus. Culture in milk changed patterns of EDTA-Tris combinational effects compared with that in standard Mueller-Hilton broth. Combined with EDTA-Tris in milk, synergic effects were observed in colistin, dihydrostreptomycin, kanamycin, erythromycin, gentamycin, oxytetracycline, streptomycin to E. coli, Str. uberis, and Str. agalactiae. However, significant antagonistic effects of milk on antibiotic susceptibility in combination with EDTA-Tris were noted in neomycin, streptomycin, penicillin, roxithromycin, and amoxicillin. This study indicates that combination therapy of EDTA-Tris with antibiotics in bovine mastitis should be used with caution because of the possible antagonistic effects of antibiotic combination with EDTA-Tris on mastitic pathogens. In addition, antibiotic susceptibility test in combination with EDTA-Tris in milk culture condition can be benefit in search of effective treatment regimen for some antibiotic-resistant bacteria of mastitis.

• Journal of Microbiology and Biotechnology
• /
• 제26권2호
• /
• pp.408-420
• /
• 2016

This study proposes an alternative approach for the use of chitosan silver-based dressing for the control of foot infection with multidrug-resistant bacteria. Sixty-five bacterial isolates were isolated from 40 diabetic patients. Staphylococcus aureus (37%) and Pseudomonas aeruginosa (18.5%) were the predominant isolates in the ulcer samples. Ten antibiotics were in vitro tested against diabetic foot clinical bacterial isolates. The most resistant S. aureus and P. aeruginosa isolates were then selected for further study. Three chitosan sources were tested individually for chelating silver nanoparticles. Squilla chitosan silver nanoparticles (Sq. Cs-Ag⁰) showed the maximum activity against the resistant bacteria when mixed with amikacin that showed the maximum synergetic index. This, in turn, resulted in the reduction of the amikacin MIC value by 95%. For evaluation of the effectiveness of the prepared dressing using Artemia salina as the toxicity biomarker, the LC₅₀ was found to be 549.5, 18,000, and 10,000 μg/ml for amikacin, Sq. Cs-Ag⁰, and dressing matrix, respectively. Loading the formula onto chitosan hydrogel dressing showed promising antibacterial activities, with responsive healing properties for the wounds in normal rats of those diabetic rats (polymicrobial infection). It is quite interesting to note that no emergence of any side effect on either kidney or liver biomedical functions was noticed.

• Journal of Veterinary Science
• /
• 제22권6호
• /
• pp.78.1-78.10
• /
• 2021

Background: Recurrent subclinical mastitis (RScM) due to resistant bacteria has low clinical and bacteriological cure rates, often requiring the culling of cows. The sequential intramammary administration of enrofloxacin hydrochloride-dihydrate (enro-C) followed by ceftiofur HCl may be useful for treating these cases. Objectives: This study assessed the bacteriological and clinical cure-efficacies of the sequentially intramammary administration of enro-C, followed by ceftiofur HCl to treat RScM in Holstein/Friesian cows. Methods: This trial was conducted in a herd with a high prevalence of RScM, and 20 Holstein/Friesian cows were included: 45% suffering subclinical mastitis and 38.9% of the mammary quarters affected. Twenty-nine bacterial isolates in vitro resistant to enro-C were obtained (coagulase-negative Staphylococcus spp, 55.2%; Staphylococcus aureus, 27.6%; Escherichia coli, 6.9%; Streptococcus uberis, 6.9%; Corynebacterium bovis, 3.4%). Polymerase chain reaction-isolated the following genes linked to enro-C resistance: chromosomal (gyrA) and plasmid (aac(6')-lb-cr). The treatments were as follows: twice-daily intramammary infusions of enro-C (300 mg/10 mL) for 5 days. Cows clinically considered treatment failures were also treated with intramammary ceftiofur (125 mg/10 mL, twice daily for 5 days. The clinical and bacteriological cure rates were carried out when completing each treatment phase and at 14 and 21 days, aided by a California mastitis test, somatic cell count, and failure to identify the initially causative bacteria. Results: Enro-C achieved 65% clinical and bacteriological cure rates, and 100% cure rates were obtained after the rescue treatment with ceftiofur HCl. Conclusions: Outstanding clinical and bacteriological cure rates in cows affected by RScM were achieved with the consecutive intramammary infusions of enro-C, followed by ceftiofur HCl.

• Journal of Microbiology and Biotechnology
• /
• 제32권2호
• /
• pp.263-267
• /
• 2022

The aim of this study was to determine whether the antibacterial activity of chitosan-modified Fe₃O₄ (CS@Fe₃O₄) nanomaterials against Acinetobacter baumannii (A. baumannii) is mediated through changes in biofilm formation and reactive oxygen species (ROS) production. For this purpose, the broth dilution method was used to examine the effect of CS@Fe₃O₄ nanoparticles on bacterial growth. The effects of CS@Fe₃O₄ nanoparticles on biofilm formation were measured using a semi-quantitative crystal violet staining assay. In addition, a bacterial ROS detection kit was used to detect the production of ROS in bacteria. The results showed that CS@Fe₃O₄ nanoparticles had a significant inhibitory effect on the colony growth and biofilm formation of drug-resistant A. baumannii (p < 0.05). The ROS stress assay revealed significantly higher ROS levels in A. baumannii subjected to CS@Fe₃O₄ nanoparticle treatment than the control group (p < 0.05). Thus, we demonstrated for the first time that CS@Fe₃O₄ nanoparticles had an inhibitory effect on A. baumannii in vitro, and that the antibacterial effect of CS@Fe₃O₄ nanoparticles on drug-resistant A. baumannii was more significant than on drug-sensitive bacteria. Our findings suggest that the antibacterial mechanism of CS@Fe₃O₄ nanoparticles is mediated through inhibition of biofilm formation in drug-resistant bacteria, as well as stimulation of A. baumannii to produce ROS. In summary, our data indicate that CS@Fe₃O₄ nanoparticles could be used to treat infections caused by drug-resistant A. baumannii.

• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2001년도 추계학술대회
• /
• pp.61-73
• /
• 2001